• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number UNK AMPLATZER SEPTAL OCCLUDER
Device Problem Off-Label Use (1494)
Patient Problems Atrial Fibrillation (1729); Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Liver Damage/Dysfunction (1954); Pneumonia (2011); Heart Failure/Congestive Heart Failure (4446)
Event Date 08/07/2023
Event Type  Death  
Manufacturer Narrative
B2 - date of death is estimated.B3 - date of event is estimated.D4 - the udi number is not known as the part and lot numbers were not provided.The additional patient effects reported in the articles are captured under a separate medwatch report.Summarized patient outcomes/complications of infarct exclusion repair of post-myocardial infarction ventricular septal rupture with a hybrid patch and septal occluder device compared to patch only were reported in a research article in a subject population with multiple co-morbidities including hypertension, diabetes, coronary artery disease, previous coronary artery bypass graft, prior percutaneous coronary intervention, acute renal failure, cardiogenic shock, preoperative intra-aortic balloon pump.Some of the complications reported were low cardiac output (co) syndrome (heart failure), atrial fibrillation, pacemaker, dialysis, stroke, pneumonia, liver failure, bleeding, surgical intervention, death these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Please note, per the instructions for use, "the amplatzer septal occluder is a percutaneous, transcatheter atrial septal defect closure device intended for occlusion of atrial septal defects (asds) in secundum position or patients who have undergone a fenestrated fontan procedure and who now require closure of the fenestration.".
 
Event Description
The article, ¿infarct exclusion repair of post-myocardial infarction ventricular septal rupture with a hybrid patch and septal occluder device compared to patch only¿, was reviewed.The article presented a retrospective single center study to compare outcomes of patients with post-mi vsd repaired using patch only or hybrid patch/sod.The device mentioned in the article is amplatzer septal occluder.The article concluded post-mi vsd repair with patch/sod has comparable short-term outcomes to patch alone.Addition of a sod to patch repair provides a scaffold that may enhance the repair of post-mi vsd with patch exclusion.[the primary and corresponding author is adam williams, duke university, 2301 erwin road, durham nc 27701, with corresponding email: arw55@duke.Edu].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key17653706
MDR Text Key322322218
Report Number2135147-2023-03781
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER SEPTAL OCCLUDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-